These data together with the initial findings that the administration of IFN-γ to MS patients exacerbated disease [30,31] supported an important role of IL-12/IFN-γ axis and Th1 cells in both EAE and MS pathogenesis. The gene discussed is IFNG; the disease is myeloid sarcoma.